Ligand Pharmaceuticals Inc (LGND)
SG&A Expense Growth
39.77%
Quarterly · Period ending:
LGND SG&A Expense Growth
Latest reported39.77%period ending
Latest reported39.77%period ending
LGND Quarterly SG&A Growth (QoQ) (0.00% → 39.77%)
Latest values, visible window
High-resolution chart · PNG
LGND sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 39.7725% | |
| -16.7459% | |
| -12.0193% | |
| 40.9963% | |
| 7.3081% | |
| -26.5729% | |
| 4.617% | |
| 38.881% | |
| 60.9259% | |
| -31.522% | |
| 9.1157% | |
| 29.8485% | |
| 3.9797% | |
| -45.3204% | |
| 33.0563% | |
| 23.4486% | |
| 1.3501% | |
| -32.7639% | |
| 39.4559% | |
| -13.5477% | |
| 16.5967% | |
| -58.058% | |
| 100.2796% | |
| 49.1707% | |
| 8.6896% | |
| -9.857% | |
| 7.895% | |
| -13.3618% | |
| -0.8478% | |
| -0.6719% | |
| 15.8829% | |
| 3.6475% | |
| 21.6015% | |
| -1.3679% | |
| 10.1962% | |
| 7.3752% | |
| -10.5572% | |
| 10.5041% | |
| 5.0912% | |
| -8.1306% | |
| 0.5568% | |
| 10.2585% | |
| 24.5222% | |
| -31.1972% | |
| 20.5372% | |
| 7.074% | |
| -16.9683% | |
| 28.6887% | |
| 3.2926% | |
| 14.7511% | |
| -7.0648% | |
| 10.4505% | |
| -4.3536% | |
| 5.1132% | |
| -2.2592% | |
| 11.2183% | |
| 12.475% | |
| 16.8056% | |
| -27.0316% | |
| 6.6148% | |
| -7.7751% | |
| -5.3871% | |
| -76.7081% | |
| 476.535% | |
| 7.9396% | |
| -83.3041% | |
| 655.942% | |
| -14.6945% | |
| -58.4715% | |
| 112.6326% | |
| -45.9268% | |
| 30.2791% | |
| -54.9361% | |
| 160.8887% | |
| -20.2842% | |
| -35.3912% | |
| -46.9471% | |
| -90.9504% | |
| 391.3468% | |
| -10.7785% | |
| -78.5008% | |
| 503.2505% | |
| 7.7525% | |
| -5.7606% | |
| 0.5936% | |
| 1.1217% | |
| 9.2862% | |
| 3.2423% | |
| 11.4229% | |
| -2.7742% | |
| 65.0121% | |
| -2.6159% | |
| 9.2146% | |
| 13.2106% | |
| 1.9506% | |
| 4.7378% | |
| 6.4299% | |
| 18.0973% | |
| 13.4888% | |
| -18.9061% |